Altrenogest

CAS No. 850-52-2

Altrenogest( Altrenogest | A 35957 | A-35957 | Allyl trenbolone | DRC 6246 | R 2267 | REGU-MATE )

Catalog No. M16177 CAS No. 850-52-2

Altrenogest(A35957; RU2267) is a progestogen structurally related to veterinary steroid trenbolone.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 42 In Stock
50MG 28 In Stock
100MG 37 In Stock
200MG Get Quote In Stock
500MG 83 In Stock
1G 120 In Stock

Biological Information

  • Product Name
    Altrenogest
  • Note
    Research use only, not for human use.
  • Brief Description
    Altrenogest(A35957; RU2267) is a progestogen structurally related to veterinary steroid trenbolone.
  • Description
    Altrenogest(A35957; RU2267) is a progestogen structurally related to veterinary steroid trenbolone.(In Vitro):Altrenogest (Allyltrenbolone) is a progestogen structurally related to veterinary steroid trenbolone. Treatment of embryo-recipient mares with Altrenogest (Allyltrenbolone) appears to be beneficial in extending the degree of donor-recipient synchrony required for successful embryo transfer. The oil and gel Altrenogest (Allyltrenbolone) preparations are equally effective in modulating estrous behavior and time to estrus and ovulation. Altrenogest (Allyltrenbolone) treatment started late in diestrus appears to result in a high incidence of ovulation during treatment and when luteolysis and ovulation occur during treatment; the subsequent luteal phase is frequently prolonged due to failure of regression of the CL.
  • In Vitro
    Altrenogest (Allyltrenbolone) is a progestogen structurally related to veterinary steroid trenbolone. Treatment of embryo-recipient mares with Altrenogest (Allyltrenbolone) appears to be beneficial in extending the degree of donor-recipient synchrony required for successful embryo transfer. The oil and gel Altrenogest (Allyltrenbolone) preparations are equally effective in modulating estrous behavior and time to estrus and ovulation. Altrenogest (Allyltrenbolone) treatment started late in diestrus appears to result in a high incidence of ovulation during treatment and when luteolysis and ovulation occur during treatment; the subsequent luteal phase is frequently prolonged due to failure of regression of the CL.
  • In Vivo
    ——
  • Synonyms
    Altrenogest | A 35957 | A-35957 | Allyl trenbolone | DRC 6246 | R 2267 | REGU-MATE
  • Pathway
    Endocrinology/Hormones
  • Target
    Estrogen Receptor/ERR
  • Recptor
    ER
  • Research Area
    Endocrinology
  • Indication
    ——

Chemical Information

  • CAS Number
    850-52-2
  • Formula Weight
    310.43
  • Molecular Formula
    C21H26O2
  • Purity
    >98% (HPLC)
  • Solubility
    Ethanol: 2 mg/mL (6.44 mM); DMSO: 62 mg/mL (199.72 mM)
  • SMILES
    C[C@@]12[C@@](CC=C)(O)CC[C@@]1([H])[C@]3([H])CCC4=CC(CCC4=C3C=C2)=O
  • Chemical Name
    (8S,13S,14S,17R)-17-allyl-17-hydroxy-13-methyl-1,2,6,7,8,13,14,15,16,17-decahydro-3H-cyclopenta[a]phenanthren-3-one

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Squires EL, et al. J Anim Sci, 1983, 56(4), 901-910.
molnova catalog
related products
  • BHPI

    BHPI is a potent, noncompetitive small molecule ERα inhibitor.

  • Palazestrant

    Palazestrant (OP-1250) is an orally available and highly potent estrogen receptor antagonist and selective ER degrader with antitumor activity.

  • AZD9496 maleate

    A potent, selective estrogen receptor downregulator (SERD) with ER downregulation pIC50 of 9.68.